RT Journal
A1 Ross JS, Nazem AG, Lurie P, Lackner JE, Krumholz HM
T1 UPdated estimates of pharmaceutical company payments to physicians in vermont
JF JAMA
JO JAMA
YR 2008
FD November 5
VO 300
IS 17
SP 1998
OP 2000
DO 10.1001/jama.2008.560
UL http://dx.doi.org/10.1001/jama.2008.560
AB 
To the Editor: We previously examined the experiences of Vermont and Minnesota with state laws requiring that pharmaceutical companies disclose payments to health care professionals.1 However, in Vermont, companies were permitted to designate payments as trade secrets, preventing their inclusion in our study. Public Citizen subsequently obtained disclosed trade-secret–designated payments through litigation against the companies. We present updated findings and comparison of trade-secret– and non–trade-secret–designated payments.